Giulia Adriani

12PUBLICATIONS
37CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersCellular nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 23, 2025
Colorectal Cancer at the Crossroads: The Good, the Bad, and the Future of Platinum-Based Drugs.

Jia Xuan Kee, Jia Ning Nicolette Yau, Ram Pravin Kumar Muthuramalingam

|Jul 07, 2025
A Targeted Redox-Active Dual-Action Pt(IV)-Mn(II) Prodrug Displays Enhanced In Vivo Anticancer Activity.

Alvaro Lopez-Sanchez, Henri Chédotal, Ram Pravin Kumar Muthuramalingam

|May 22, 2024
Fluorescence-Guided Spatial Drug Screening in 3D Colorectal Cancer Spheroids.

Jia Ning Nicolette Yau, Thirumal Yempala, Ram Pravin Kumar Muthuramalingam

|Sep 22, 2023
Themis controls T cell activation, effector functions, and metabolism of peripheral CD8+ T cells.

Namrata Gautam, Lukasz Wojciech, Jiawei Yap

|Feb 02, 2023
G9a/GLP inhibition during ex vivo lymphocyte expansion increases in vivo cytotoxicity of engineered T cells against hepatocellular carcinoma.

Maxine S Y Lam, Jose Antonio Reales-Calderon, Jin Rong Ow

Pageof 2